Not applicableStudy completedNCT05712096What this trial is testingEVusheld Assessment reaL wORld Effectiveness in Israel Clalit Health ServicesWho this might be right forSARS-CoV-2COVID-19 AstraZeneca 4,000
Early research (Phase 1)Study completedNCT01715909What this trial is testingA Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza InfectionWho this might be right forInfluenza Hoffmann-La Roche 20
Early research (Phase 1)Study completedNCT00535236What this trial is testingAn Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002)Who this might be right forHerpes ZosterHerpes Zoster-related Complications Merck Sharp & Dohme LLC 341
Not applicableUnknownNCT06223100What this trial is testingEfficacy and Safety of the Combination Therapy Based on Eravacycline in Immunocompromised Hosts With MDROS InfectionWho this might be right forImmune Dysregulation Disorder Sichuan Provincial People's Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT02532452What this trial is testingThird Party Viral Specific T-cells (VSTs)Who this might be right forViral InfectionViral ReactivationInfection in an Immunocompromised Host Children's Hospital Medical Center, Cincinnati 750
Testing effectiveness (Phase 2)Study completedNCT01924793What this trial is testingAn Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) InfectionWho this might be right forParainfluenza Ansun Biopharma, Inc. 23
Testing effectiveness (Phase 2)Study completedNCT00556998What this trial is testingA Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised AdolescentsWho this might be right forPharmacokinetics Pfizer 26
Testing effectiveness (Phase 2)Looking for participantsNCT06597916What this trial is testingRSV Vaccination in Immunocompromised Patients.Who this might be right forRSV Infection Medical University of Vienna 200
Testing effectiveness (Phase 2)Study completedNCT01383993What this trial is testingStudy Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal InfectionWho this might be right forAspergillosis, Aspergilloma Pfizer 21
Large-scale testing (Phase 3)Study completedNCT00003031What this trial is testingComparison of Voriconazole and Amphotericin B in Treating Patients With AspergillosisWho this might be right forInfectionPulmonary Complications European Organisation for Research and Treatment of Cancer - EORTC 212
Large-scale testing (Phase 3)Study completedNCT00002339What this trial is testingFluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune SystemsWho this might be right forCandidiasis, EsophagealHIV Infections Pfizer 100
Not applicableUnknownNCT01617759What this trial is testingAspergillus-specific PCR Assay in Cerebrospinal Fluid Samples for Detection of Central Nervous System AspergillosisWho this might be right forAspergillosisInfection in an Immunocompromised Host Heidelberg University 200
Large-scale testing (Phase 3)Looking for participantsNCT07013474What this trial is testingLearn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely ImmunocompromisedWho this might be right forCOVID-19 Infection Pfizer 300
Large-scale testing (Phase 3)WithdrawnNCT06028841What this trial is testingA Clinical Phase 3 Trial of VLA1553 in Adult Participants with Human Immunodeficiency Virus (HIV)Who this might be right forChikungunya Virus Infection Valneva Austria GmbH
Large-scale testing (Phase 3)Study completedNCT03525210What this trial is testingStudy of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised PatientsWho this might be right forHuman Papilloma VirusHivOrgan Transplants Universitaire Ziekenhuizen KU Leuven 271
Large-scale testing (Phase 3)Study completedNCT00001757What this trial is testingAn Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal InfectionsWho this might be right forMycoses National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Study completedNCT05438602What this trial is testingLearn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 and a Compromised Immune SystemWho this might be right forCOVID-19 Pfizer 158
Large-scale testing (Phase 3)Active Not RecruitingNCT06067230What this trial is testingInvestigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk AdultsWho this might be right forRespiratory Syncytial Virus ModernaTX, Inc. 1,153
Not applicableUnknownNCT01902030What this trial is testingEvaluation of Performance of An Aspergillus PCR in Tissue and Pleural Effusion Samples of Immunocompromised PatientsWho this might be right forAspergillosisImmunosuppression Heidelberg University 100
Testing effectiveness (Phase 2)Study completedNCT00739934What this trial is testingStudy Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal InfectionWho this might be right forCandidiasisCandidemia Pfizer 40